Previous Section
Drug Therapy
1. Long-Term Survival after Gemcitabine and Cisplatin in Patients with Locally Advanced Transitional Cell Carcinoma of the Bladder: Focus on Supplementary Treatment Strategies.
- Author
- Als AB; Sengelov L; von der Maase H;
- Institution
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
- Journal
- Eur Urol. 2007 Mar 15;.
- Abstract URL
- Click here to view abstract
2. Chemotherapy for metastatic or unresectable bladder cancer.
- Author
- Bellmunt J; Albiol S;
- Institution
- Hospital del MAR-IMAS, Autonoma University of Barcelona, Barcelona, Spain. jbellmunt@imas.imim.es
- Journal
- Semin Oncol. 2007 Apr;34(2):135-44.
- Abstract URL
- Click here to view abstract
3. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
- Author
- Sternberg CN;
- Institution
- Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. cstern@mclinik.it
- Journal
- Semin Oncol. 2007 Apr;34(2):122-8.
- Abstract URL
- Click here to view abstract
4. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.
- Author
- Weiss C; Engehausen DG; Krause FS; Papadopoulos T; Dunst J; Sauer R; Rodel C; Weiss C; Engehausen DG; Krause FS; Papadopoulos T; Dunst J; Sauer R; Rodel C;
- Institution
- Department of Radiation Therapy, University of Erlangen, Universitatsstrasse 27. 91054 Erlangen, Germany. Christian.Weiss@strahlen.med.uni-erlangen.de
- Journal
- Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1072-80. Epub 2007 Apr 30.
- Abstract URL
- Click here to view abstract
5. Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy.
- Author
- Takata R; Katagiri T; Kanehira M; Shuin T; Miki T; Namiki M; Kohri K; Tsunoda T; Fujioka T; Nakamura Y;
- Institution
- Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, Japan.
- Journal
- Cancer Sci. 2007 Jan;98(1):113-7.
- Abstract URL
- Click here to view abstract
6. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?
- Author
- Mazhar D; Ali N; Ngan S;
- Institution
- Journal
- Future Oncol. 2007 Feb;3(1):5-8.
7. Chemotherapy for muscle-invasive bladder cancer in the perioperative setting: current standards.
- Author
- Dreicer R;
- Institution
- Department of Solid Tumor Oncology, Taussig Cancer Center and the Glickman Urologic Institute, Cleveland Clinic, Cleveland, OH 44195, USA. dreicer@ccf.org
- Journal
- Urol Oncol. 2007 Jan-Feb;25(1):72-5.
- Abstract URL
- Click here to view abstract
Next: Surgical Therapy
